Akums Q1 Revenue Up 14%, EBITDA Surges 35%

Event Type: Q1 FY27 Earnings Conference Call for discussion of unaudited financial results
Event Date & Time: Monday, August 10, 2026 at 12:00 P.M. (IST)
Management Participants: Mr. Sanjeev Jain (Managing Director), Mr. Sandeep Jain (Managing Director), Mr. Sumeet Sood (Chief Financial Officer), Mr. Sahil Maheshwari (Head, Strategy), Mr. Ankit Jain (Head, Investor Relations)
Moderator: Mr. Umesh Laddha from Ambit Capital
Financial Period Discussed: Quarter ended June 30, 2026 (Q1 FY27)
Presentation Availability: The investor presentation was shared prior to the call on Saturday, August 8, 2026
Transcript Availability: The transcript will be available on the Company's website at https://www.akums.in/investors/investors-meet/
Compliance Statement: The management included standard forward-looking statements disclaimer and indicated that any discussion might include predictions or projections of future events

Financial Highlights Discussed:

Operating revenue stood at ₹1,167 crores, increase of 13.9% YoY (Q1 FY26: ₹1,024 crores)
Operating EBITDA was ₹175 crores, increase of 35.4% YoY (Q1 FY26: ₹129 crores)
EBITDA margins at 15%, improving 238 basis points YoY
PAT stood at ₹101 crores, increase of 56.1% YoY (Q1 FY26: ₹65 crores)
Cash surplus of ₹1,616 crores, with operating cash flow of ₹65 crores for the quarter

Segment Performance:

CDMO segment: Revenue ₹964 crores (+18.6% YoY), EBITDA ₹163 crores (+36.8% YoY)
Domestic branded formulation: Revenue ₹115 crores (+7.3% YoY), EBITDA ₹12 crores (-25.4% YoY)
International branded formulation: Revenue ₹35 crores (-1.5% YoY), EBITDA ₹6.9 crores (-14.4% YoY)
API segment: Revenue ₹32 crores (-29.7% YoY), EBITDA -₹4 crores (improved from -₹6 crores in Q1 FY26)
Trade generic business: Revenue ₹21 crores (-9.5% YoY), EBITDA at breakeven (₹0.1 crores)

Strategic Updates:

Acquisition of Oriflame India's manufacturing business announced on July 23, 2026, covering two manufacturing facilities (Roorkee, Uttarakhand and Noida, Uttar Pradesh) and a leased warehouse in Noida
Expansion into skin care cosmetics and wellness products
Zambia order expected to reflect in current financial year (approximately $25 million/~₹240 crores)
European business expected to kickstart in next financial year
New facility in Baddi being set up for oral manufacturing capabilities, expected to go live by end of FY27

The document includes the complete transcript of the earnings conference call
The transcript contains detailed Q&A session with analysts from Citigroup, Naredi Investment, Cogito, Enam Holdings, Avendus Spark, VVD Asset Managers, VGSPL, and ICICI Securities
Financial data was extensively discussed and disclosed during the call